Company

Omniose

Biotechnology Research 18 employees

Employees: 18
Contacts: 2
Emails: 2
Phones: 1

www.omniose.com LinkedIn Crunchbase

Omniose Overview

Website: www.omniose.com
Industry: Biotechnology Research
Employees: 18
Funding: 3.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Omniose

Omniose was founded in 2016 based on the pioneering glycoconjugation discoveries of our scientific founders Mario Feldman and Christian Harding through a scientific collaboration that characterized a new class of conjugating enzymes. The research operations were established at BioGenerator Labs in St. Louis and the company was previously known as VaxNewMo. Omniose has been awarded $11.8 million in grants from the US NIAID for use of our platform technology to develop vaccines against Group B Streptococcus, Klebsiella pneumoniae, and Streptococcus pneumoniae. In January 2024, the company announced an exclusive collaboration agreement with AstraZeneca for up to three years to research potential vaccines for bacterial pathogens.

Omniose Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Omniose Org Chart

Sample employees and titles

Name	Title	Location	Contact
Jessica Stella	Director, Business Operations	St Louis, Missouri, United States	Email Phone
Cassie Orf Higgins	Lab Manager at Omniose	St Charles, Missouri, United States	View
Rachel Edwards	Research Scientist at Omniose	St Louis, Missouri, United States	Email
Timothy Cooke	CEO of Omniose, Vaccines Vs. Superbugs		View